Skip to content
Search

Latest Stories

NICE appoints Prof Gillian Leng new chief executive

The National Institute for Health and Care Excellence (NICE) today named Professor Gillian Leng as its new chief executive.

She will take over on 1 April from Sir Andrew Dillon, who has led the organisation since its  establishment in 1999.


“NICE has a unique and unparalleled history and we wish to thank Andrew for his outstanding leadership over the last two decades,” said Tim Irish, interim chair of NICE.

“Looking ahead, NICE has a very exciting and ambitious future, and the Board is unanimously agreed that Gill has the leadership qualities to take us forward.”

Sir Andrew Dillon added: “She is an outstanding leader and has all the qualities needed to lead the organisation into its third decade. I am entirely confident that NICE will be safe and successful in her hands.”

Leng has been serving the organisation as deputy chief executive since 2007. She also holds the post of Director of Health and Social Care.

The appointment follows an open competition, NICE noted.

Leng commented: “Under Andrew’s leadership NICE has gained a formidable reputation both nationally and internationally as a world leader in guidance development. I am honoured and privileged to have been appointed as its second Chief Executive.

“I look forward to working with the Institute’s staff and stakeholders as we enter an exciting new chapter of innovative changes to deliver our portfolio of guidance into the hands of frontline staff in an easy and intuitive way.”

A visiting professor at King’s College London, Leng trained in medicine at University of Leeds and worked on clinical trials and epidemiological research in University of Edinburgh, and in London as a consultant in public health medicine.

At NICE, she was responsible for the initial set up and running of the clinical guidelines programme, for establishing the NICE implementation function, and for setting up NHS Evidence.

She also played an instrumental role in the NICE accreditation programme, guideline development in social care, and the NICE programmes of indicators and quality standards.

Leng was appointed a CBE in the 2011 Birthday Honours.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less